Results 51 to 60 of about 2,391,041 (267)

Clinical trials on trial [PDF]

open access: yesEuropean Journal of Hospital Pharmacy, 2012
It has been 3 years since I wrote an editorial on the topic of uncertainty around new cancer treatments (issue 4 of volume 2009). Has this field progressed in 3 years? I think the answer is both yes and no. Yes because we now have a clearer picture of why cancer drugs can sometimes act differently (usually worse) in real life situations than they seem ...
openaire   +2 more sources

An [Imperfect] Case for Dyadic Research in Pediatric Psychosocial Oncology

open access: yes
Pediatric Blood &Cancer, EarlyView.
Stephanie M. Nanos   +2 more
wiley   +1 more source

Early Impact of Childhood Opportunity on Neurocognitive Outcomes in Sickle Cell Disease

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Introduction Neurocognitive impairment is a well‐recognized complication of sickle cell disease (SCD) that begins early in childhood and persists across development. While cerebrovascular injury contributes substantially to risk, neurocognitive deficits are also observed in children without overt or silent cerebral infarctions, suggesting ...
Julia E. LaMotte   +5 more
wiley   +1 more source

شهود المحاكم في روما إبان القرن الأخير من العصر الجمهوري [PDF]

open access: yesMağallaẗ Kulliyyaẗ Al-Adāb Bi-Qinā
يتناول البحث موضوع "شهود المحاكم في روما إبان القرن الأخير من العصر الجمهوري, للتعرف على دور شهود المحاكم بوصفهم دليل الإثبات الأساسي الذي لجأ إليه أطراف الخصومة في روما إبان القرن الأخير من العصر الجمهوري, والشروط الواجب توافرها في الشاهد (testis ...
محمد محمود محمد على
doaj   +1 more source

Psychosocial Functioning After Pediatric Bone Sarcoma: Generic and Survivor‐Specific Outcomes in Adolescent and Young Adult Patients

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background Pediatric bone sarcoma patients and survivors may experience psychosocial challenges related to childhood cancer after their intensive, body‐altering treatment. This cross‐sectional study aimed to evaluate generic and survivor‐specific psychosocial outcomes in a national cohort of pediatric bone sarcoma patients and survivors, and ...
Hinke van der Hoek   +14 more
wiley   +1 more source

A multicenter single‐arm objective performance criteria trial evaluating the efficacy and safety of a dedicated venous sinus thrombectomy device for severe cerebral venous sinus thrombosis

open access: yesNeuroprotection
Aim Approximately 21% of patients with cerebral venous sinus thrombosis (CVST) are refractory to anticoagulation treatment and face poor prognosis. These patients may benefit from endovascular therapy.
Shadamu Yusuying   +11 more
doaj   +1 more source

Computed Tomography Angiography in Peripheral Arterial Disease: Comparison of Three Image Acquisition Techniques to Optimize Vascular Enhancement—Randomized Controlled Trial

open access: yesFrontiers in Cardiovascular Medicine, 2020
Objectives: To prospectively compare three image acquisition techniques in lower extremity CT angiography: the “standard” anterograde technique (SA), the adaptive anterograde technique (AA), and the retrograde acquisition technique (RA).Materials and ...
David C. Rotzinger   +8 more
doaj   +1 more source

To trial or not to trial?

open access: yes
The authors consider the interactive session they facilitated at the 2024 Third Space Symposium on trialling technologies in education as third space practitioners.
Hodgins, Colleen, Millgate, Naomi
openaire   +1 more source

Ironic Medications: A Narrative‐Based Psycho‐Educational Intervention to Explore Patient–Provider Communication in Adolescents With Haematological Cancer

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background Adolescents with haematological malignancies face significant emotional and relational challenges, often accompanied by difficulties in communicating their needs within the healthcare context. To address these issues, a narrative‐based psycho‐educational intervention based on the creation and prescription of Ironic Medications was ...
Marta Stoppa   +7 more
wiley   +1 more source

Incidence and Severity of Carboplatin‐Associated Hearing Loss in Children With Cancer Assessed by the SIOP Boston 2012 Ototoxicity Criteria

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background Platinum‐based chemotherapy is known to cause severe and debilitating hearing loss, but unlike cisplatin, the true incidence of carboplatin‐induced hearing loss remains unclear. We evaluated functional hearing outcomes in children receiving carboplatin to determine the incidence and severity of ototoxicity. Procedure We identified a
Aniket Chawla   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy